LH, d. V., L, L., B, d. K., IH, B. R., & MR, V. (2022). Sentinel lymph node detection in thyroid carcinoma using 68Ga-tilmanocept PET/CT: A proof-of-concept study protocol. Future oncology (London, England), 18(31), 3493. https://doi.org/10.2217/fon-2022-0165
Chicago Style (17th ed.) CitationLH, de Vries, Lodewijk L, de Keizer B, Borel Rinkes IH, and Vriens MR. "Sentinel Lymph Node Detection in Thyroid Carcinoma Using 68Ga-tilmanocept PET/CT: A Proof-of-concept Study Protocol." Future Oncology (London, England) 18, no. 31 (2022): 3493. https://doi.org/10.2217/fon-2022-0165.
MLA (9th ed.) CitationLH, de Vries, et al. "Sentinel Lymph Node Detection in Thyroid Carcinoma Using 68Ga-tilmanocept PET/CT: A Proof-of-concept Study Protocol." Future Oncology (London, England), vol. 18, no. 31, 2022, p. 3493, https://doi.org/10.2217/fon-2022-0165.